OR5BC1P

Across TCGA pan-cancer cohorts, OR5BC1P RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated OR5BC1P data layer.

The strongest signal is observed in mesothelioma (MESO), where higher OR5BC1P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR5BC1P expression acts as an unfavorable survival marker.

MESO, BRCA, and DLBC are the cancer types where OR5BC1P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	III,IV	0.069	0.580	<.001	108	view →
BRCA	OS	Tertile	III,IV	0.165	0.833	<.001	42	view →
DLBC	DFS	Tertile	II,III,IV	0.099	0.808	<.001	36	view →
BLCA	OS	Tertile	IV	0.052	0.575	<.001	18	view →
SKCM	DFS	Tertile	IV	0.016	0.454	<.001	18	view →
KIRC	DFS	Tertile	All	0.275	0.641	.006	12	view →
SARC	DFS	Tertile	All	0.213	0.597	.028	9	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

OR5BC1P–MESO (OS)

Open the MESO breakdown →